% Expired Patents = 40.0

CIPO Patents = 2

EPO Patents = 2

Forward Citations = 156

Loading Chart...

5 inventors (with patents filed for the assignee):

Horst Lindhofer (5 out of 20 patents)

Markus M Heiss (2 out of 9 patents)

Shimon Slavin (1 out of 24 patents)

4. Shoshana Morecki (1 out of 1 patent)

5. Peter Ruf (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 8709421 - Combination of the application of antibodies for immunostimulation together with glucocorticoids (2014-04-29),

2. 8663638 - Intraoperative trifunctional antibody application for prophylaxis of intraperitoneal tumor cell dissemination (2014-03-04),

3. 8277806 - Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites (2012-10-02),

4. 8066989 - Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy (2011-11-29),

5. 6994853 - Time-staggered utilization of tumor cells in combination with intact antibodies for immunization (2006-02-07),

Company Overview

Trion Pharma GmbH is a leading pharmaceutical company specializing in the development and distribution of innovative therapies for various medical conditions. With a focus on research and development, Trion Pharma is committed to improving patient outcomes and quality of life. Their products are developed using cutting-edge technology and adhere to the highest quality standards. Visit their website for more information.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#297 in W-8000 Munich

#6,098 in Germany

Munich, Germany

Trion Pharma Gmbh

Forward Citations = 156

5 inventors:

Horst Lindhofer (5 out of 20 patents)

Markus M Heiss (2 out of 9 patents)

Shimon Slavin (1 out of 24 patents)

4. Shoshana Morecki (1 out of 1 patent)

5. Peter Ruf (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Trion Pharma Gmbh. Retrieved from https://idiyas.com/company/trion-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]